日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Make me your Homepage
left corner left corner
China Daily Website

Fighting Africa's biggest epidemic

Updated: 2013-12-02 00:19
By Li Wenfang in Guangzhou ( China Daily)

Guangdong company spearheads efforts to help prevent and eradicate killer disease

Fighting Africa's biggest epidemic

Guangdong New South Group promotes its anti-malaria medicine in Nigeria. Photo provided to China Daily

Chinese medicines could well prove to be the panacea for African nations in tackling malaria, a disease that accounts for the greatest number of deaths on the continent.

While big donors such as the US-based Gates Foundation and British drugmaker GlaxoSmithKline are spearheading the fight by spending huge amounts on long-term solutions such as preventive vaccines, valuable support is also being provided by Chinese drug firms with medicines that seek to stop the disease at the carrier stage.

Leading Chinese efforts is Guangdong New South Artepharm Co, which has taken a twin-pronged approach to fighting malaria in Africa. The company, a unit of the Guangzhou-based diversified business enterprise Guangdong New South Group Co, plans to tackle the disease with its artemisinin-based anti-malarial medicines and also increase awareness about the disease on the ground with its spirited public campaigns.

"We have been stepping up our overseas marketing efforts, actively participating in trade shows and establishing offices in the malaria-endemic areas of Africa, Southeast Asia and South America," says Chen Yuejin, vice-president of Guangdong New South Group.

Founded in 1994, the privately held company is engaged in manufacturing traditional Chinese medicine, property development, hotel services, energy development and financial services.

Its business extends across more than 20 cities in the Chinese mainland along with overseas locations such as Singapore, Australia, Kenya and Nigeria. According to Chen, the company has offices in 16 African countries, with the largest presence being in Nigeria, with representative offices in Abuja, Lagos and Kano.

Chen says the company has also embarked on a brand-building initiative through public campaigns and advertisements in buses and on the radio. The real efforts will also focus on getting the company co-opted as an anti-malarial bulk drug supplier for international organizations, governments and charitable groups, which account for 70 to 80 percent of the global anti-malarial medicine market.

Malaria is Africa's deadliest disease, killing more than 600,000 people every year, mostly children. Billions of dollars are spent every year to find new ways to check the spread of the disease in Africa. The Chinese efforts will no doubt prove valuable, experts say.

Guangdong New South made its foray into anti-malarial medicine in 2006 by teaming up with the Guangzhou University of Chinese Medicine. The company decided to market Artemisinin, an anti-malarial drug extracted from artemisia annua, or sweet wormwood plants that are native to China.

According to company officials, Guangdong New South has extensive sweet wormwood plantations in Fengshun county, Meizhou, Guangdong province, along with extraction units. The company has already applied for patent protection in 57 countries for its anti-malarial medicines and is a registered supplier in 14 African countries, Cambodia and Myanmar.

Chen says that after extensive clinical trials in the African island nation of Comoros, the company perfected what is now called the "Fast Elimination of Malaria through Source Eradication".

"We achieved remarkable results," Chen says, adding that the trials took place on the island of Moheli in Comoros, where 23 percent of the 36,000 residents were carriers of plasmodium, the parasite responsible for human malaria.

All residents on Moheli took the malaria medicine twice daily, and in four months the percentage dropped to 0.33 percent, he says. "Three years after the trials, the plasmodium carriage rate fell to just 1 to 2 percent."

"We repeated the trials in Anjouan, another island with a population of 310,000, last year and succeeded in bringing the plasmodium carriage rate down from 19 percent to 0.5 percent," Chen says, adding that the process would be extended to other parts of Comoros soon.

Guangdong New South delivered 24 million yuan ($3.94 million) of anti-malarial medicine in June to the Ministry of Health to support China's global efforts in tackling malaria.

"Ninety percent of the 660,000 malaria deaths reported worldwide last year occurred in Africa. The disease still kills one African child every minute," says Luis Sambo, the regional director for the World Health Organization in Africa.

Chen from Guangdong New South says that apart from marketing efforts, the company is also investing in free trade zones to attract more Chinese investors to Africa.

Guangdong New South has through its fully owned unit in Lagos acquired a 51 percent stake in China-Africa Investment Co from State-owned Guangdong Xinguang International Group. China-Africa Investment operates the Nigeria Ogun Guangdong Free Trade Zone in Ogun, Nigeria. The zone covers an area of 100 square kilometers and houses more than 30 enterprises.

"The zone will be attractive for Chinese companies that are planning expansion in Africa," says Chen.

Previous Page 1 2 Next Page

 
8.03K
 
...
主站蜘蛛池模板: 日韩在线观看第一页 | 亚洲九九夜夜 | 噜噜色网 | 国产高清在线精品一区αpp | 亚洲精品久久久久一区二区三 | 国产免费福利网站 | 江苏少妇性BBB搡BBB爽爽爽 | 亚洲日韩aⅴ在线视频 | 色老师影院 | 一级毛片免费视频 | 欧美精品一区在线 | 精品国产欧美一区二区 | 久久久久九九九九 | 久久精品免费视频观看 | 久操视频网 | 亚洲成人免费在线 | 欧美a在线看 | 高清中文字幕免费观在线 | 国产一区亚洲一区 | 日本高清天码一区在线播放 | 色欲AV色情国产又爽又色 | 美女被网站大全在线视频 | 久久草视频这里只精品99 | 婷婷尹人香蕉久久天堂 | 九九热视频这里只有精品 | 日本人妖miran护士 | 毛片成人网| 亚洲欧洲视频在线观看 | 99这里只有精品视频 | 84pao强力打造 | 视频一区 精品自拍 | 黄视频网站在线看 | 成人欧美网站免费 | 日本黄色免费片 | α片毛片| 成人禁在线观看网站 | 国产精品一区在线观看你懂的 | 欧美经典剧情系列h版在线观看 | 亚洲www啪成人一区二区麻豆 | 男女猛烈激情xx00免费视频 | 日韩av中文在线 |